A detailed history of Nan Fung Group Holdings LTD transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 11,122 shares of MDGL stock, worth $3.86 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
11,122
Previous 9,762 13.93%
Holding current value
$3.86 Million
Previous $2.07 Million 65.67%
% of portfolio
3.4%
Previous 2.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$202.45 - $354.85 $275,332 - $482,596
1,360 Added 13.93%
11,122 $3.43 Million
Q3 2024

Nov 13, 2024

BUY
$212.22 - $292.96 $865,857 - $1.2 Million
4,080 Added 71.81%
9,762 $2.07 Million
Q1 2024

May 14, 2024

BUY
$171.37 - $283.23 $771,165 - $1.27 Million
4,500 Added 380.71%
5,682 $1.52 Million
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $142,312 - $280,287
1,182 New
1,182 $273,000
Q4 2022

Feb 13, 2023

BUY
$58.39 - $296.54 $69,016 - $350,510
1,182 New
1,182 $343,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.